生物假体主动脉瓣退变的决定因素
长期研究纳入466例1994至2014年间行外科生物假体主动脉瓣置换的患者,随访中位112.3个月,以超声心动图评估瓣膜血流动力学退化(VHD,定义为平均跨假体压差≥30 mmHg和/或至少中度瓣膜反流)。383例完整随访者中70例(18.3%;每瓣年4.8%)发生VHD,中位32.4个月。多变量回归显示血肌酐>2.1 mg/dl、猪源组织瓣、动脉高血压和患者-假体不匹配与VHD相关;Kaplan-Meier分析显示老年患者VHD发展更快。
要点
- VHD定义为超声心动图平均跨假体压差≥30 mmHg和/或至少中度瓣膜反流。
- 完整随访患者中18.3%发生VHD,每瓣年发生率为4.8%,中位发生时间32.4个月。
- VHD的相关因素包括血肌酐>2.1 mg/dl、猪源组织瓣、动脉高血压和患者-假体不匹配。
核心结论
- 基于超声心动图,每五例外科生物假体心脏瓣膜置换患者中约一例发生VHD;VHD与肾功能损害、使用猪源组织瓣、动脉高血压和患者-假体不匹配相关;年龄小于70岁的患者未受VHD更快发展的影响。
研究设计与样本
- 长期研究,纳入466例1994年至2014年间行外科生物假体主动脉瓣置换的连续患者(平均年龄73.5±7.5岁,56.0%为女性),在基线和随访时进行临床评估、经胸超声心动图和实验室检查。
诊断标准与关键数值
- VHD定义为超声心动图平均跨假体压差≥30 mmHg和/或至少中度瓣膜反流;患者-假体不匹配定义为有效瓣口面积指数≤0.8 cm2/m2。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of the present long-term study was to assess the incidence and mode of valve hemodynamic deterioration (VHD) of bioprosthetic aortic valves, as well as associated factors.
BACKGROUND: Modern definitions of bioprosthetic valve deterioration recommend the use of echocardiography for the assessment of transprosthetic gradients and valvular regurgitation.
METHODS: A total of 466 consecutive patients (mean age 73.5 ± 7.5 years, 56.0% women) underwent surgical bioprosthetic aortic valve replacement between 1994 and 2014. Clinical assessment, transthoracic echocardiography, and laboratory testing were performed at baseline and follow-up. VHD was defined as mean transprosthetic gradient ≥30 mm Hg and/or at least moderate valvular regurgitation on echocardiography. Patient-prosthesis mismatch was defined as an effective orifice area indexed to body surface area ≤0.8 cm2/m2.
RESULTS: Patients were followed for a median of 112.3 months (interquartile range: 57.7 to 147.7 months). Among patients with complete follow-up (n = 383), 70 subjects (18.3%; 4.8% per valve-year) developed VHD after a median of 32.4 months (interquartile range: 12.9 to 87.2 months; stenosis, n = 45; regurgitation, n = 16; both, n = 9). Factors associated with VHD by multivariate regression analysis were serum creatinine >2.1 mg/dl (hazard ratio [HR]: 4.143; 95% confidence interval [CI]: 1.740 to 9.866; p = 0.001), porcine tissue valves (HR: 2.241; 95% CI: 1.356 to 3.706; p = 0.002), arterial hypertension (HR: 3.022; 95% CI: 1.424 to 6.410; p = 0.004), and patient-prosthesis mismatch (HR: 1.931; 95% CI: 1.102 to 3.384; p = 0.022). By Kaplan-Meier analysis, elderly subjects showed faster development of VHD (age <70 years, 133.5 months [95% CI: 116.2 to 150.8 months]; 70 to 80 years, 129.1 months [95% CI: 112.4 to 145.7 months]; >80 years, 100.3 months [95% CI: 63.6 to 136.9 months]; p = 0.023). By multivariate Cox regression, age, diabetes, concomitant coronary artery bypass grafting, creatinine, and VHD (p < 0.05) were significantly associated with mortality.
CONCLUSIONS: On the basis of echocardiography, every fifth patient developed VHD after surgical bioprosthetic heart valve replacement. VHD was associated with renal impairment, the use of porcine tissue valves, arterial hypertension, and patient-prosthesis mismatch. Patients younger than 70 years were not affected by faster VHD.
引用
- Nitsche C, Kammerlander AA, Knechtelsdorfer K, et al. Determinants of Bioprosthetic Aortic Valve Degeneration. JACC Cardiovasc Imaging. 2019. PMID: 30878425. doi:10.1016/j.jcmg.2019.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。